Navigation Links
New Antibiotic Could Shorten TB Treatment
Date:4/2/2009

Less time to completion may boost patient compliance, outcomes, researchers say

THURSDAY, April 2 (HealthDay News) -- Using a new antibiotic called moxifloxacin in combination with other drugs could cut several months off the six months it currently takes to cure patients with drug-treatable tuberculosis, according to a phase 2 study.

Long treatment times can result in patients failing to complete their drug therapy, so a shorter period of treatment could improve patient compliance, the researchers noted. Shorter TB treatment regimens would also reduce the workload for overburdened TB control programs, especially in countries with high TB rates.

The study included 170 TB patients treated at a hospital in Rio de Janeiro, Brazil, who were receiving a standard combination of three first-line TB drugs. They were randomly selected to receive as their fourth drug either moxifloxacin 400 milligrams, along with an ethambutol placebo (85 patients), or ethambutol (15-20 mg per kilogram of body weight) plus moxifloxacin placebo (85 patients) five days a week for eight weeks.

The drug ethambutol is widely used in TB treatment but has very little activity and was used as a control in this study.

After eight weeks, 80 percent of patients in the moxifloxacin group tested negative for TB, compared with 63 percent of patients in the ethambutol group. A total of 16 negative events (eight in each group) were reported in 12 patients, but only one of those events was linked to moxifloxacin, according to Dr. Richard E. Chaisson, of the Center for Tuberculosis Research at Johns Hopkins University School of Medicine in Baltimore, and colleagues.

The study is in the April 4 edition of The Lancet.

"The results of our trial have substantial implications for future trials. First, the improved culture conversion rate found after 8 weeks in the experimental group suggest that moxifloxacin, in combination with other first-line anti-tuberculosis drugs, could shorten the time needed to cure tuberculosis by several months," the research team wrote.

More information

The American Lung Association has more about tuberculosis.



-- Robert Preidt



SOURCE: The Lancet, news release, April 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Giant Food Extends Its Free Antibiotic Prescription Program Through July 11, 2009
2. Rep. Slaughter Reintroduces Bill to Help Fight Antibiotic Resistance Crisis by Combating Misuse of Antibiotics in Animal Agriculture
3. Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act
4. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals: Risks of Overusing Antibiotics
5. A Broad-Spectrum Antibiotic with Activity Against MRSA and Pseudomonas Aeruginosa Would Earn a Higher Patient Share in the U.S. than in Europe for the Treatment of Hospital-Acquired Pneumonia
6. Antibiotic Combo Fights Resistant TB
7. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
8. Antibiotic-Resistant Meningitis Reported in U.S.
9. Health experts urge supermarket pharmacies to get smart about free antibiotics
10. Activity Against Drug-Resistant Pathogens is One of the Leading Attributes Influencing Physicians Antibiotic Selection for the Treatment of Inpatient Community-Acquired Pneumonia
11. Could carbon dioxide replace antibiotics in surgery?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Antibiotic Could Shorten TB Treatment
(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology: